Statin treatment prevents increased cardiovascular and all-cause mortality associated with clarithromycin in patients with stable coronary heart disease

Journal of Cardiovascular Pharmacology

Volumn 55, Issue 2, 2010, Pages 123-128

  Jensen, Gorm B ^a   Hilden, Jørgen ^b   Als Nielsen, Bodil ^a   Damgaard, Morten ^a   Hansen, Jørgen Fischer ^a   Hansen, Stig ^a   Helø, Olav H ^c   Hildebrandt, Per ^a   Kastrup, Jens ^c   Kolmos, Hans Jørn ^d   Kjøller, Erik ^a   Lind, Inga ^e   Nielsen, Henrik ^a   Petersen, Lars ^a   Jespersen, Christian M ^a   Gluud, Christian ^c  

^a Mental Health Center Glostrup   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c Rigshospitalet   (Denmark)

^d ODENSE UNIVERSITY HOSPITAL   (Denmark)

^e STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLARITHROMYCIN; DIGOXIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRITE; PLACEBO;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA BASE; DRUG FATALITY; DRUG POTENTIATION; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SINGLE BLIND PROCEDURE; TREATMENT DURATION; TREATMENT OUTCOME; COMPARATIVE STUDY; CORONARY DISEASE; ENZYMOLOGY; MIDDLE AGED; TRENDS;

AGED; CLARITHROMYCIN; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; MORTALITY; TREATMENT OUTCOME;

EID: 77649326713     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e3181c87e37     Document Type: Article

References (22)

1. Gupta S, Leatham EV, Carrington D, et al. Elevated Chlamydia pneumoniae antibodies, cardiovascular events and azithromycin in male survivors of myocardial infarction. Circulation. 1997;96:404-407. (Pubitemid 27329411)
2. Muhlestein JB, Anderson JL, Carlquist JF, et al. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC study. Circulation. 2000;102: 1755-1760.
3. Gurfinkel E, Bozovich G, Beck E, et al. Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes: the final report of the ROXIS study. Eur Heart J. 1999;20:121-127.
4. Zahn R, Schneider S, Frilling B, et al;Working Group of Leading Hospital Cardiologists. Antibiotic Therapy After Acute Myocardial Infarction (ANTIBIO): a prospective randomized trial. Circulation. 2003;107: 1253-1259.
5. Cercek B, Shah PK, Noc M, et al; AZACS Investigators. Effect of short- term treatment with azithromycin on recurrent ischaemic events in patients with acute coronary syndrome in the AZithromycin in Acute Coronary Syndrome (AZACS) trial: a randomized controlled trial. Lancet. 2003;361:809-813.
6. Grayston JT, Kronmal RA, Jackson LA, et al; ACES Investigators. Azithromycin for the secondary prevention of coronary events. N Engl J Med. 2005;352:1637-1645.
7. Cannon CP, Braunwald E, McCabe CH, et al. Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome. N Engl J Med. 2005;352:1646-1654.
8. O'Connor CM, Dunne MW, Pfeffer MA, et al; Investigators in the WIZARD Study. Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study, a randomized controlled trial. JAMA. 2003;290:1459-1466.
9. Jespersen CM, Als-Nielsen B, Damgaard M, et al; CLARICOR Trial Group. Randomised placebo controlled multicentre trial to assess short term clarithromycin for patients with stable coronary heart disease: CLARICOR trial. BMJ. 2006;332:22-27.
10. Gluud C, Als-Nielsen B, Damgaard M, et al; CLARICOR Trial Group. Clarithromycin for two weeks for stable coronary heart disease: six-year follow-up of the CLARICOR randomized trial and updated meta-analysis of antibiotics for coronary heart disease. Cardiology. 2008;111:280-287.
11. de Boer OJ, van der Wal AC, Houtkamp MA, et al. Unstable atherosclerotic plaques contain T-cells that respond to Chlamydia pneumoniae. Cardioavasc Res. 2000;48:402-408.
12. Hansson GK. Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol. 2001;21:1876-1890.
13. Vaughan CJ, Gotte AM, Basson CT. The evolving role of statins in the management of atherosclerosis. J Am Coll Cardiol. 2000;35:1-10.
14. Schartl M, BockschW, Koschyk DH, et al. Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease. Circulation. 2001;104:387-392.
15. Tahara N, Kai H, Ishibashi M, et al. Simvastatin attenuates plaque inflammation. J Am Coll Cardiol. 2006;48:1825-1831.
16. Yip HK, Sun CK, Chang LT, et al. Strong suppression of high-sensitivity C-reactive protein level and its mediated pro-atherosclerotic effects with simvastatin: in vivo and in vitro studies. Int J Cardiol. 2007;121: 253-260.
17. Nissen SE, Tuzcu EM, Schoenhagen P, et al; Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) Investigators. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. N Engl J Med. 2005;352:29-38.
18. Yildiz A, Cakar MA, Baskurt M, et al. The effects of atorvastatin therapy on endothelial function in patients with coronary artery disease. Cardiovasc Ultrasound. 2007;5:51.
19. Douglas K, O'Malley PG, Jackson JL. Meta-analysis: the effect of statins on albuminuria. Ann Intern Med. 2006;145:117-124.
20. Kastrup J, Johansen JS, Winkel P, et al; CLARICOR Trial Group. High serum YKL-40 concentration is associated with cardiovascular and all-cause mortality in patients with stable coronary artery disease. Eur Heart J. 2009;30:1066-1072.
21. Gislason GH, Rasmussen JN, Abildstrøm SZ, et al. Long-term compliance with beta-blockers, angiotensin converting enzyme inhibitors, and statins after acute myocardial infarction. Eur Heart J. 2006;27: 1153-1158.
22. Andraws R, Berger JS, Brown DL. Effects of antibiotic therapy on outcomes of patients with coronary artery disease. A meta-analysis of randomized controlled trials. JAMA. 2005;293:2641-2647.